News

This year‘s Science Award of the German Stifterverband ‚Research with Responsibility‘ goes to Jörg Overmann, Scientific Director of the Leibniz Institute DSMZ-German Collection of Microorganisms and

This year again, from November 18 to 24, attention is being drawn worldwide to the threatening increase in resistance to antibiotics and other antimicrobial agents. The World Health Organisation (WHO)

Around 300 million people are living with a chronic hepatitis B virus (HBV) infection and currently there is no cure for the disease. A team of researchers around DZIF professor Ulrike Protzer from

As part of her autumn tour, the Federal Minister of Education and Research, Bettina Stark-Watzinger, visited the Helmholtz Centre for Infection Research (HZI) and the German Center for Infection

When you hear about tuberculosis, the first thing that comes to mind is lung disease. However, almost 30 percent of tuberculosis cases in Germany affect extrapulmonary organs. The disease, triggered

Between 10 and 20 million people worldwide are infected with hepatitis D virus (HDV). HDV infection is always associated with hepatitis B virus infection. So far there has been no satisfactory

Tuberculosis is one of the leading causes of death worldwide, with an estimated 1.4 million deaths and ten million people infected annually. Resistant and multidrug-resistant (MDR) variants of the

In the early 20th century, French scientists Albert Calmette and Camille Guérin developed a vaccine from the bovine tuberculosis bacterium Mycobacterium bovis, which was named BCG (Bacillus Calmette

Finding active agents against SARS-CoV-2 and other coronaviruses—this goal has been pursued by DZIF scientist Prof Thomas Schulz and his team at Hannover Medical School (MHH) since the virus first